Wilson Sonsini Law Firm Promotes 23 to Partner - Silicon Valley Daily svdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from svdaily.com Daily Mail and Mail on Sunday newspapers.
- Wilson Sonsini s partner-elect class includes one non-binary person, eight women, and 14 men from the firm s corporate, litigation, intellectual pro.
/PRNewswire/ Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today.
/PRNewswire/ Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, today.
Share this article
Share this article
NEW YORK, April 5, 2021 /PRNewswire/ Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today announced the appointment of Cyril Konto, M.D., to the new position of Chief Medical Officer (CMO), effective immediately.
Dr. Konto, who reports to Chief Executive Officer Alessandro Riva, M.D., will oversee oncology clinical sciences, clinical operations, regulatory sciences, drug metabolism and pharmacokinetics, biometrics, drug safety, and quality. He will also work closely with the discovery and antibody engineering organizations to select and set priorities for research targets.
Previously, Dr. Konto was vice president of clinical development at Allogene Therapeutics, which was spun off from Pfizer in 2018. At Pfizer, he was global head of early immuno-oncology clinical development. Earlier, he worked in both medical affairs and clinical development at Bristol